1 Recovery |
8 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
1.1 Fanggan decoction versus conventional medicine |
1 |
95 |
Risk Ratio (M‐H, Random, 95% CI) |
1.02 [0.67, 1.56] |
1.2 Fever resolved within 24 hours after treatment (Lianhua Qingwen capsule versus oseltamivir) |
1 |
145 |
Risk Ratio (M‐H, Random, 95% CI) |
0.95 [0.66, 1.38] |
1.3 Fever resolved within 24 hours after treatment (Lianhua Qingwen capsule versus control 2) |
1 |
145 |
Risk Ratio (M‐H, Random, 95% CI) |
1.91 [1.03, 3.52] |
1.4 Ganmao capsule versus amantadine |
1 |
738 |
Risk Ratio (M‐H, Random, 95% CI) |
0.48 [0.38, 0.61] |
1.5 Ganmao capsule versus amantadine (Day 2) |
1 |
432 |
Risk Ratio (M‐H, Random, 95% CI) |
5.17 [3.82, 6.99] |
1.6 E Shu You versus ribavirin (Day 3) |
1 |
61 |
Risk Ratio (M‐H, Random, 95% CI) |
2.18 [0.87, 5.43] |
1.7 Tanreqing + oseltamivir versus oseltamivir |
2 |
197 |
Risk Ratio (M‐H, Random, 95% CI) |
1.32 [0.87, 2.00] |
1.8 TCM versus oseltamivir |
1 |
60 |
Risk Ratio (M‐H, Random, 95% CI) |
1.13 [0.50, 2.52] |
1.9 Antiwei versus placebo (day 4) |
1 |
225 |
Risk Ratio (M‐H, Random, 95% CI) |
3.80 [1.23, 11.72] |
2 Time to fever clearance |
10 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
2.1 TCM versus oseltamivir |
3 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.2 Gegeng Tang granule + oseltamivir versus oseltamivir |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.3 Lianhua Qingwen capsule versus oseltamivir |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.4 TCM + oseltamivir versus oseltamivir |
3 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.5 Tanreqing injection + oseltamivir versus oseltamivir |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2.6 Fanggan granule versus conventional medicine |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3 Duration of cough |
4 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
3.1 Fanggan decoction versus conventional medicine |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3.2 Ge Geng Tang granule + oseltamivir versus oseltamivir |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3.3 Tanreqing injection + oseltamivir versus oseltamivir |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3.4 TCM versus oseltamivir |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
4 Time to remission of muscle pain |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
4.1 Lianhua Qingwen capsule |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
4.2 TCM versus oseltamivir |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
5 Time to symptom remission |
4 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
5.1 TCM versus oseltamivir |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
5.2 Fanggan granule versus conventional medicine |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
5.3 Gegeng Tang granule + oseltamivir versus oseltamivir (body pain) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
5.4 TCM + oseltamivir versus oseltamivir |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
6 Time to remission of sore throat |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
6.1 TCM versus oseltamivir |
1 |
60 |
Mean Difference (IV, Fixed, 95% CI) |
‐15.60 [‐17.87, ‐13.33] |
7 Length of hospital stay |
4 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
7.1 TCM versus oseltamivir |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
7.2 Tanreqing injection + oseltamivir versus oseltamivir |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
7.3 TCM plus oseltamivir versus oseltamivir |
2 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
7.4 TCM versus placebo |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
8 No improvement or worsening influenza |
7 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
8.1 E Shu You versus ribavirin (Day 3) |
1 |
61 |
Risk Ratio (M‐H, Random, 95% CI) |
0.40 [0.14, 1.17] |
8.2 Fanggan decoction versus conventional medicines |
1 |
95 |
Risk Ratio (M‐H, Random, 95% CI) |
0.70 [0.24, 2.05] |
8.3 Tanreqing injection + oseltamivir versus oseltamivir |
2 |
197 |
Risk Ratio (M‐H, Random, 95% CI) |
0.37 [0.17, 0.80] |
8.4 TCM versus oseltamivir |
1 |
60 |
Risk Ratio (M‐H, Random, 95% CI) |
2.0 [0.19, 20.90] |
8.5 Lianhua Qingwen versus oseltamivir |
1 |
145 |
Risk Ratio (M‐H, Random, 95% CI) |
1.0 [0.22, 4.46] |
8.6 Lianhua Qingwen versus Anga huangmin |
1 |
145 |
Risk Ratio (M‐H, Random, 95% CI) |
0.20 [0.09, 0.46] |
8.7 Ganmao capsule versus amantadine |
1 |
951 |
Risk Ratio (M‐H, Random, 95% CI) |
0.15 [0.10, 0.21] |
9 Partial improvement |
6 |
703 |
Risk Ratio (M‐H, Random, 95% CI) |
1.05 [0.82, 1.36] |
9.1 Tanreqing injection + oseltamivir |
1 |
110 |
Risk Ratio (M‐H, Random, 95% CI) |
0.6 [0.23, 1.54] |
9.2 Fanggan granule versus Western medicine |
1 |
95 |
Risk Ratio (M‐H, Random, 95% CI) |
1.09 [0.66, 1.78] |
9.3 Lianhua Qingwen versus oseltamivir |
1 |
145 |
Risk Ratio (M‐H, Random, 95% CI) |
1.2 [0.50, 2.87] |
9.4 Lianhua Qingwen capsule versus An ga huang min |
1 |
145 |
Risk Ratio (M‐H, Random, 95% CI) |
1.2 [0.50, 2.87] |
9.5 Tanreqing + oseltamivir versus oseltamivir |
1 |
87 |
Risk Ratio (M‐H, Random, 95% CI) |
1.29 [0.84, 1.96] |
9.6 TCM versus oseltamivir |
1 |
60 |
Risk Ratio (M‐H, Random, 95% CI) |
0.44 [0.15, 1.29] |
9.7 E Shu You versus ribavirin |
1 |
61 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.36, 2.27] |
10 Adverse events |
10 |
1011 |
Risk Ratio (M‐H, Random, 95% CI) |
0.54 [0.26, 1.11] |
10.1 TCM versus oseltamivir |
3 |
154 |
Risk Ratio (M‐H, Random, 95% CI) |
1.12 [0.04, 32.35] |
10.2 Lianhua Qingwen versus oseltamivir |
3 |
241 |
Risk Ratio (M‐H, Random, 95% CI) |
0.34 [0.11, 1.02] |
10.3 Fanggan granule versus conventional medicine |
1 |
95 |
Risk Ratio (M‐H, Random, 95% CI) |
0.98 [0.14, 6.67] |
10.4 Antiwei versus placebo |
1 |
225 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
10.5 Tanreqing plus oseltamivir versus oseltamivir |
1 |
87 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
10.6 E Shu You versus Lymbaweilim |
1 |
61 |
Risk Ratio (M‐H, Random, 95% CI) |
0.60 [0.11, 3.36] |
10.7 Lianhua Qingwen versus An ga huang min |
1 |
148 |
Risk Ratio (M‐H, Random, 95% CI) |
0.73 [0.08, 6.78] |